Cours Axis-Shield Ltd

Actions

Temps Différé London S.E. Autres places de cotation			Varia. 5j.	Varia. 1 janv.
- ^GBX	-.--%		-.--%	-.--%

Durée

Période

Style

Axis Shield : The Effect of Food Intake on the Pharmacokinetics of Vadadustat Following Single Dose Administration	29/07/20
Axis Shield : Randomized, Double-Blinded, Active-Controlled (Darbepoetin Alfa), Phase 3 Study of Vadadustat in Chronic Kidney Disease Patients With Anemia on Hemodialysis in Japan	29/07/20
Axis Shield : Preclinical Characterization of Vadadustat (AKB-6548), an Oral Small Molecule Hypoxia Inducible Factor Prolyl-4-Hydroxylase Inhibitor, for the Potential Treatment of Renal Anemia	29/07/20
Axis Shield : Targeted Literature Review of Patient-reported Burden of Anemia in Chronic Kidney Disease	29/07/20
Efficacy and Safety of Vadadustat, an Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor, Being Evaluated for the Treatment of Anemia Due to Chronic Kidney Disease (CKD) in Japanese Subjects: Results from Phase 2 Studies (encore)	29/07/20

Axis-Shield Ltd est une société basée au Royaume-Uni. La société développe, fabrique et commercialise des produits de diagnostic in-vitro.

Secteur

	Varia. 1 janv.	Capi.
AXIS-SHIELD LTD	-.--%	0
BIOMÉRIEUX	+0,89 %	12,8 Md
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-10,29 %	7,61 Md
DIASORIN S.P.A.	+1,78 %	5,41 Md
AUTOBIO DIAGNOSTICS CO., LTD.	-1,16 %	4,51 Md
LANTHEUS HOLDINGS, INC.	+5,74 %	4,49 Md
10X GENOMICS, INC.	-50,70 %	3,3 Md
ANDON HEALTH CO., LTD.	+12,21 %	2,73 Md
VITROLIFE AB	-16,13 %	2,02 Md
GUANGZHOU WONDFO BIOTECH CO.,LTD	-11,50 %	1,73 Md